Neoantigen-based Melanoma-Poly-ICLC Vaccine

Known as: NeoVax Melanoma Vaccine 
A peptide-based melanoma cancer vaccine consisting of neoantigens and peptides derived from patient-specific melanoma immunogenic epitopes, combined… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background Peptide vaccines offer the opportunity to elicit glioma-specific T cells with tumor killing ability. Using antigens… (More)
  • table 1
  • table 2
Is this relevant?
2019
2019
Immunotherapy, including therapeutic vaccines, is increasingly being developed for patients with high-grade glioma, and… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2012
2012
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Background MUC1 is aberrantly expressed in a… (More)
Is this relevant?